Rare Disease Trial, Recruiting NCT00369421 Sponsor: National Human Genome Research Institute (NHGRI) Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Recruiting

NCT00369421
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You may be eligible if you are 1 month of age or older and have a known or suspected inherited metabolic disorder, genetic condition, or hereditary disease risk.
  • Children between 1 month and 2 years of age (or under 12 kg in weight) may be considered after a review by the pediatric team.
  • Children over 2 years of age may join if they are in stable health and need to be admitted to the Clinical Center for diagnosis.
  • Family members of someone already diagnosed with a condition may participate to help with testing or to act as a comparison (control) for their relative's diagnosis.
  • Healthy adult volunteers aged 18 or older may join to provide blood and urine samples for comparison purposes.
  • Participants may be seen in person as inpatients or outpatients, or via video appointment, depending on the research team's decision.

Who may not be able to join:

  • Babies under 1 month of age cannot take part, as the Clinical Center is better set up to care for older individuals.
  • Children over 2 years of age who are medically unstable and do not need to be admitted to the Clinical Center for diagnosis cannot join.
  • Women who are pregnant are not eligible to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: William A Gahl, M.D., National Human Genome Research Institute (NHGRI)

Phone: (301) 402-2739

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Human Genome Research Institute (NHGRI)
Registry
ClinicalTrials.gov
Start date
12 September 1978

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Clinical phenotyping

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov